Heidi Waters, PhD, MBA

Barriers and Drivers of Adopting a Digital Medication Adherence Technology: Understanding the Factor Analysis Results

Background: A new digital medicine technology combining an ingestible event monitoring (IEM) sensor with an oral antipsychotic to track ingestion and adherence may be beneficial. However,...

William Carpenter , MD;

Joshua Liberman , PhD;

Felicia Forma , BSc;

Charles Ruetsch , PhD;

Jennifer Clerie , BS ;

Tigwa Davis , PhD;

Heidi Waters , PhD, MBA;

Dawn Velligan , PhD;

Delbert Robinson , MD;

Chris Jaeger , MD, MBA;

11/22/2019

The Frameworks to Support Adherence in Mental Health Working Group: Translating Science Into Action to Improve Patient Care

Shared decision making (SDM) involves healthcare providers and patients collaborating to make optimal healthcare decisions that align with patients’ goals and values. Patient decision aid...

Heidi Waters , PhD, MBA;

Dawn Velligan , PhD;

Felicia Forma , BSc;

Susan Bergeson ;

Martha Sajatovic , MD;

Jason Caplan , MD;

Michael Measom , MD;

Monica Oss , MS;

Michael Townsend , MA;

03/01/2019

Antipsychotic Treatment Communication Patterns: Predictors and Follow-up Risk

Discussing treatment compliance is challenging when patients have serious mental illness. Little is known about compliance-related discussions between healthcare providers and patients. ...

Heidi Waters , PhD, MBA;

Carolyn Martin , MSW;

John P. White , MD, DPM, MS;

Eleena Koep , MS;

Angela Belland , BS ;

Felicia Forma , BSc;

03/01/2019

Creation of an Actionable Knowledge Toolkit for Evidence-Based Psychiatric Care

Objectives Measurement-based care (MBC) refers to using data from assessments to make clinical decisions. Recently the Relapse Assessment for Schizophrenia Patients (RASP), a patient sel...

Bre Banks , PhD;

Heidi Waters , PhD, MBA;

Kristin Pareja , PharmD;

Ruth Duffy , PhD;

10/08/2020

The Cost of Improving Treatment Choices: Cost and Benefit of a Digital Medicine System that Collects and Reports Objective Medication Adherence

Background: Medication adherence is critical for relapse prevention among SMI patients. In the absence of objectively collected adherence data (OCAD), managing medications is difficult. A...

Felicia Forma , BSc;

Christopher P. Young , MD, PhD;

Charles Ruetsch , PhD;

Heidi Waters , PhD, MBA;

11/22/2019

A Comparison of Barriers and Drivers Between Prescribing and Non-Prescribing Psychiatric Care Providers Regarding Use of Digital Medication Adherence Platforms

Background: Tracking medication adherence through an ingestible event monitoring (IEM) sensor could benefit seriously mentally ill patients (SMI). Psychiatric providers may be reluctant t...

Jennifer Clerie , BS ;

Charles Ruetsch , PhD;

Heidi Waters , PhD, MBA;

Tigwa Davis , PhD;

Dawn Velligan , PhD;

Delbert Robinson , MD;

Chris Jaeger , MD, MBA;

William Carpenter , MD;

Joshua Liberman , PhD;

Felicia Forma , BSc;

11/22/2019